Efficacy of Local Anesthetic Through Continuous Infusion


Ascension Genesys Hospital

Status and phase

Phase 3


Pain Control


Combination Product: Bupivacaine infusion
Combination Product: Saline

Study type


Funder types




Details and patient eligibility


Efficacy of using continuous infusion of local anesthetic for post operative pain control following laparotomy.

Full description

This study will evaluate the benefits of placing an analgesic pain pump in laparotomy incisions with the addition of intravenous/oral pain medications as needed versus using solely intravenous and oral pain medications as needed for post-operative pain management. The goal of this study will be to decrease the usage of narcotics in post-operative laparotomy patients by providing local incision pain relief. This will be a double blinded randomized control study with placebo with two groups of patients: One with a local anesthetic infusion pump filled with Bupivacaine, a local anesthetic, after laparotomy and the other group with an infusion pump filled with normal saline. The pain pumps will be placed in the OR. Post-operatively, all patients will have the standard pain regimen available to them during their stay. Surgeons will monitor the patient for 4 days post-operatively and the infusion pain pump will be removed on post-operative day 4. Investigator will then look back through each patient's records and gather the amount of pain medications that they requested during their stay. Both groups will then have their data collected in the same manner and placed for data analysis. - The standard pain regimen will include a morphine IV 4mg every 4 hours and Hydrocodone-acetominophen 5/325 Q6H PRN. If a patient controlled analgesia infusion pump is needed this will be considered a need for increase in pain management. Every patient will be started on this pain regimen post operatively. During their stay, If the patient requires an increase in their pain medication, the supervising attending will determine which drug will be added in improve their pain. At the end of the patients stay, the amount of narcotic usage will be compiled and turned into morphine equivalents in order to compare them with the control group.


120 estimated patients




18+ years old


No Healthy Volunteers

Inclusion criteria

- Patients scheduled for elective laparotomy

Exclusion criteria

  • Emergency laparotomy
  • Pregnancy
  • Patients on chronic pain medication

Trial design

120 participants in 2 patient groups, including a placebo group

Infused analgesic
Active Comparator group
Patients will be assigned to receive local anesthetic through continuous infusion by pump.
Combination Product: Bupivacaine infusion
Infused saline
Placebo Comparator group
Patients will be assigned to receive saline through continuous infusion by pump.
Combination Product: Saline

Trial contacts and locations



Central trial contact

Tarik Wasfie, MD; Kimberly Barber, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems